New Jersey · 2026-2027 Regular Session · Bill
A 5534: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 5534 is a bill introduced in the New Jersey House on September 24, 2026. According to its official title, it concerns: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder. Primary sponsor: Anthony Verrelli (Democratic). Most recent recorded action (September 24, 2026): Introduced, Referred to Assembly Health Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Anthony Verrelli | Primary sponsor | Democratic | House | 15 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Health Committee